Evaluation of radiation dose to pediatric patients during certain special procedures

This study was intended to measure pediatric entrance surface air kerma (ESAK) and effective dose during micturating cystourethrography (MCU), intravenous urography (IVU) and barium studies (barium meal, enema, and swallow) and to propose a local diagnostic reference level (DRL). ESAK was measured f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Radiation physics and chemistry (Oxford, England : 1993) England : 1993), 2014-11, Vol.104, p.267-271
Hauptverfasser: Sulieman, A., Alzimami, K., Elhag, B., Babikir, E., Alsafi, K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This study was intended to measure pediatric entrance surface air kerma (ESAK) and effective dose during micturating cystourethrography (MCU), intravenous urography (IVU) and barium studies (barium meal, enema, and swallow) and to propose a local diagnostic reference level (DRL). ESAK was measured for patients using calibrated thermoluminescent dosimeters (TLDs, GR200A). Effective doses (E) were calculated using the National Radiological Protection Board (NRPB) software. A total of 236 special pediatric procedures were investigated. 21.7% of the sample comprised barium procedures, 18.6% were MCU procedures while 59.5% of the sample were IVU procedures. The mean ESAK measurements (mGy) were 2.1±0.8, 3.0±23 and 1.2±0.2 for barium meal, enema and swallow in the same order. The mean patient dose for IVU procedures was 12.4±8.7mGy per procedure and the mean patient dose per MCU procedure was 5.8±7mGy. Local DRLs were proposed for all procedures. The patient doses in this study are within the reported values, suggesting that pediatric patients are adequately protected. •Pediatric radiation dose has been evaluated for three of the most common fluoroscopic procedures.•Radiation doses were measured using calibrated TLD GR200A.•Pediatric patients of concern and ESAK doses showed large variations.•The patient doses in this study are within the reported studies suggesting that the pediatric patients are adequately protected.
ISSN:0969-806X
1879-0895
DOI:10.1016/j.radphyschem.2013.11.034